{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:25:57Z","timestamp":1792553157111,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA257446"],"award-info":[{"award-number":["R01CA257446"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA275193"],"award-info":[{"award-number":["R01CA275193"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA180995"],"award-info":[{"award-number":["P50CA180995"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA009560"],"award-info":[{"award-number":["T32CA009560"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F31CA271826"],"award-info":[{"award-number":["F31CA271826"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["2017CHAL2008"],"award-info":[{"award-number":["2017CHAL2008"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX002479"],"award-info":[{"award-number":["CX002479"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007923","name":"University of Wisconsin Carbone Cancer Center","doi-asserted-by":"publisher","award":["P30CA014520-UW"],"award-info":[{"award-number":["P30CA014520-UW"]}],"id":[{"id":"10.13039\/100007923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    FOXA1 is a prostate lineage-specifying transcription factor that is frequently dysregulated or mutated in prostate cancer (PCa). While FOXA1 has been reported to exhibit both PCa-promoting and -inhibitory functions, its role within an immune-proficient PCa context remains unclear. Here, we show that prostate-specific deletion of\n                    <jats:italic>Foxa1<\/jats:italic>\n                    in\n                    <jats:italic>Pten<\/jats:italic>\n                    -deficient mice drives tumor progression by reprogramming luminal PCa cells toward a basal\/squamous-like state and promoting an immunosuppressive tumor microenvironment. Histological and transcriptomic analyses reveal aggressive tumors with extensive basal\/squamous features, a reactive stroma, and disorganized tissue architecture. Mechanistically, FOXA1 directly represses basal\/squamous and inflammatory genes, which become activated upon its depletion. This is accompanied by an accumulation of immunosuppressive myeloid cells, dysfunctional T cells, and immunosuppressive cytokine signaling. Together, these findings demonstrate a tumor-suppressive role for FOXA1 as an enforcer of luminal identity, such that its loss drives basal\/squamous de-differentiation, inflammatory response, and immunosuppression.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-71121-8","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:26:42Z","timestamp":1774708002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FOXA1 loss drives basal\/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-7185","authenticated-orcid":false,"given":"Lourdes","family":"Brea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viriya","family":"Keo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9403-9939","authenticated-orcid":false,"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambhavi","family":"Senthil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Breneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-0762","authenticated-orcid":false,"given":"Xiaodong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Degraff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2963-2899","authenticated-orcid":false,"given":"Sarki A.","family":"Abdulkadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kosoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-380X","authenticated-orcid":false,"given":"Jonathan C.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-7647","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2852-7675","authenticated-orcid":false,"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2326-0409","authenticated-orcid":false,"given":"Jindan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"71121_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239\u2013243 (2012).","journal-title":"Nature"},{"key":"71121_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","volume":"571","author":"EJ Adams","year":"2019","unstructured":"Adams, E. J. et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature 571, 408\u2013412 (2019).","journal-title":"Nature"},{"key":"71121_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","volume":"571","author":"A Parolia","year":"2019","unstructured":"Parolia, A. et al. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. Nature 571, 413\u2013418 (2019).","journal-title":"Nature"},{"key":"71121_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li, J. et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature 580, 93\u201399 (2020).","journal-title":"Nature"},{"key":"71121_CR5","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1210\/me.2003-0020","volume":"17","author":"N Gao","year":"2003","unstructured":"Gao, N. et al. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol. Endocrinol. 17, 1484\u20131507 (2003).","journal-title":"Mol. Endocrinol."},{"key":"71121_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4972","volume":"5","author":"HJ Jin","year":"2014","unstructured":"Jin, H. J., Zhao, J. C., Wu, L., Kim, J. & Yu, J. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program. Nat. Commun. 5, 3972 (2014).","journal-title":"Nat. Commun."},{"key":"71121_CR7","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","volume":"132","author":"M Lupien","year":"2008","unstructured":"Lupien, M. et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958\u2013970 (2008).","journal-title":"Cell"},{"key":"71121_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nature10006","volume":"474","author":"D Wang","year":"2011","unstructured":"Wang, D. et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474, 390\u2013394 (2011).","journal-title":"Nature"},{"key":"71121_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1172\/JCI122367","volume":"129","author":"B Song","year":"2019","unstructured":"Song, B. et al. Targeting FOXA1-mediated repression of TGF-beta signaling suppresses castration-resistant prostate cancer progression. J. Clin. Invest 129, 569\u2013582 (2019).","journal-title":"J. Clin. Invest"},{"key":"71121_CR10","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1158\/0008-5472.CAN-12-3468","volume":"73","author":"HJ Jin","year":"2013","unstructured":"Jin, H. J., Zhao, J. C., Ogden, I., Bergan, R. C. & Yu, J. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis. Cancer Res. 73, 3725\u20133736 (2013).","journal-title":"Cancer Res"},{"key":"71121_CR11","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1038\/onc.2017.50","volume":"36","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. FOXA1 inhibits prostate cancer neuroendocrine differentiation. Oncogene 36, 4072\u20134080 (2017).","journal-title":"Oncogene"},{"key":"71121_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell 161, 1215\u20131228 (2015).","journal-title":"Cell"},{"key":"71121_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41422-019-0204-1","volume":"29","author":"B Xu","year":"2019","unstructured":"Xu, B. et al. Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression. Cell Res. 29, 773\u2013775 (2019).","journal-title":"Cell Res"},{"key":"71121_CR14","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1038\/s41388-022-02423-6","volume":"41","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A. Oncogene 41, 4259\u20134270 (2022).","journal-title":"Oncogene"},{"key":"71121_CR15","doi-asserted-by":"publisher","unstructured":"He, Y. et al. FOXA1 overexpression suppresses interferon signaling and immune response in cancer. J. Clin. Investig. 131, https:\/\/doi.org\/10.1172\/JCI147025 (2021).","DOI":"10.1172\/JCI147025"},{"key":"71121_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1200\/JCO.19.01638","volume":"38","author":"ES Antonarakis","year":"2020","unstructured":"Antonarakis, E. S. et al. Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study. J. Clin. Oncol. 38, 395\u2013405 (2020).","journal-title":"J. Clin. Oncol."},{"key":"71121_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","volume":"15","author":"ED Kwon","year":"2014","unstructured":"Kwon, E. D. et al. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 15, 700\u2013712 (2014).","journal-title":"Lancet Oncol."},{"key":"71121_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.eururo.2020.07.032","volume":"78","author":"K Fizazi","year":"2020","unstructured":"Fizazi, K. et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur. Urol. 78, 822\u2013830 (2020).","journal-title":"Eur. Urol."},{"key":"71121_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ccell.2020.08.007","volume":"38","author":"P Sharma","year":"2020","unstructured":"Sharma, P. et al. Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial. Cancer Cell 38, 489\u2013499.e483 (2020).","journal-title":"Cancer Cell"},{"key":"71121_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2019.00603","volume":"10","author":"N Vitkin","year":"2019","unstructured":"Vitkin, N., Nersesian, S., Siemens, D. R. & Koti, M. The Tumor Immune Contexture of Prostate Cancer. Front Immunol. 10, 603 (2019).","journal-title":"Front Immunol."},{"key":"71121_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz, T. et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat. Commun. 14, 663 (2023).","journal-title":"Nat. Commun."},{"key":"71121_CR22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2019.10.029","volume":"179","author":"S Jiao","year":"2019","unstructured":"Jiao, S. et al. Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy. Cell 179, 1177\u20131190.e1113 (2019).","journal-title":"Cell"},{"key":"71121_CR23","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","volume":"39","author":"Y Kfoury","year":"2021","unstructured":"Kfoury, Y. et al. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell 39, 1464\u20131478.e1468 (2021).","journal-title":"Cancer Cell"},{"key":"71121_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","volume":"27","author":"MX He","year":"2021","unstructured":"He, M. X. et al. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat. Med. 27, 426\u2013433 (2021).","journal-title":"Nat. Med."},{"key":"71121_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-019-0931-3","volume":"20","author":"MA Reimers","year":"2019","unstructured":"Reimers, M. A., Slane, K. E. & Pachynski, R. K. Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: Past and Future Strategies for Optimization. Curr. Urol. Rep. 20, 64 (2019).","journal-title":"Curr. Urol. Rep."},{"key":"71121_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nm.4463","volume":"24","author":"M Bezzi","year":"2018","unstructured":"Bezzi, M. et al. Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms. Nat. Med. 24, 165\u2013175 (2018).","journal-title":"Nat. Med"},{"key":"71121_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang, G. et al. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression. Cancer Discov. 6, 80\u201395 (2016).","journal-title":"Cancer Discov."},{"key":"71121_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","volume":"12","author":"L Yang","year":"2019","unstructured":"Yang, L., Li, A., Lei, Q. & Zhang, Y. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. J. Hematol. Oncol. 12, 125 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"71121_CR29","doi-asserted-by":"publisher","unstructured":"Pang, L. et al. Epigenetic regulation of tumor immunity. J. Clin. Investig. 134, https:\/\/doi.org\/10.1172\/JCI178540 (2024).","DOI":"10.1172\/JCI178540"},{"key":"71121_CR30","doi-asserted-by":"publisher","unstructured":"Brea, L. & Yu, J. Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer. Trends Endocrinol. Metabol. https:\/\/doi.org\/10.1016\/j.tem.2024.12.003 (2025).","DOI":"10.1016\/j.tem.2024.12.003"},{"key":"71121_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrurol.2018.9","volume":"15","author":"T Jamaspishvili","year":"2018","unstructured":"Jamaspishvili, T. et al. Clinical implications of PTEN loss in prostate cancer. Nat. Rev. Urol. 15, 222\u2013234 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"71121_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang, S. et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4, 209\u2013221 (2003).","journal-title":"Cancer Cell"},{"key":"71121_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nature13638","volume":"515","author":"D Di Mitri","year":"2014","unstructured":"Di Mitri, D. et al. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature 515, 134\u2013137 (2014).","journal-title":"Nature"},{"key":"71121_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"Toso, A. et al. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 9, 75\u201389 (2014).","journal-title":"Cell Rep."},{"key":"71121_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34871-9","volume":"13","author":"N Li","year":"2022","unstructured":"Li, N. et al. ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression. Nat. Commun. 13, 7281 (2022).","journal-title":"Nat. Commun."},{"key":"71121_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0925-4773(00)00551-7","volume":"101","author":"X Wu","year":"2001","unstructured":"Wu, X. et al. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mechanisms Dev. 101, 61\u201369 (2001).","journal-title":"Mechanisms Dev."},{"key":"71121_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/labinvest.2014.64","volume":"94","author":"DJ DeGraff","year":"2014","unstructured":"DeGraff, D. J. et al. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype. Lab Invest 94, 726\u2013739 (2014).","journal-title":"Lab Invest"},{"key":"71121_CR38","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/pros.22677","volume":"73","author":"JP Michiel Sedelaar","year":"2013","unstructured":"Michiel Sedelaar, J. P., Dalrymple, S. S. & Isaacs, J. T. Of mice and men\u2013warning: intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively. Prostate 73, 1316\u20131325 (2013).","journal-title":"Prostate"},{"key":"71121_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.696537","volume":"8","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study. Front Mol. Biosci. 8, 696537 (2021).","journal-title":"Front Mol. Biosci."},{"key":"71121_CR40","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1530\/ERC-12-0085","volume":"19","author":"DA Barron","year":"2012","unstructured":"Barron, D. A. & Rowley, D. R. The reactive stroma microenvironment and prostate cancer progression. Endocr. Relat. Cancer 19, R187\u2013R204 (2012).","journal-title":"Endocr. Relat. Cancer"},{"key":"71121_CR41","doi-asserted-by":"publisher","unstructured":"Tamalunas, A. et al. Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer. Prostate Cancer Prostatic Dis. https:\/\/doi.org\/10.1038\/s41391-024-00831-1 (2024).","DOI":"10.1038\/s41391-024-00831-1"},{"key":"71121_CR42","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","volume":"20","author":"AS Castanza","year":"2023","unstructured":"Castanza, A. S. et al. Extending support for mouse data in the Molecular Signatures Database (MSigDB). Nat. Methods 20, 1619\u20131620 (2023).","journal-title":"Nat. Methods"},{"key":"71121_CR43","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1158\/1078-0432.CCR-24-0060","volume":"30","author":"MC Dallos","year":"2024","unstructured":"Dallos, M. C. et al. Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer. Clin. Cancer Res 30, 5218\u20135230 (2024).","journal-title":"Clin. Cancer Res"},{"key":"71121_CR44","doi-asserted-by":"publisher","first-page":"14565","DOI":"10.1073\/pnas.251140998","volume":"98","author":"M Mercader","year":"2001","unstructured":"Mercader, M. et al. T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Proc. Natl. Acad. Sci. 98, 14565\u201314570 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"71121_CR45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.humimm.2010.02.007","volume":"71","author":"MD Morse","year":"2010","unstructured":"Morse, M. D. & McNeel, D. G. Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses. Hum. Immunol. 71, 496\u2013504 (2010).","journal-title":"Hum. Immunol."},{"key":"71121_CR46","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental Relationships of Four Exhausted CD8(+) T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms. Immunity 52, 825\u2013841.e828 (2020).","journal-title":"Immunity"},{"key":"71121_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cels.2023.03.008","volume":"14","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA. Cell Syst. 14, 404\u2013417.e404 (2023).","journal-title":"Cell Syst."},{"key":"71121_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"71121_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin, S., Plikus, M. V. & Nie, Q. CellChat for systematic analysis of cell\u2013cell communication from single-cell transcriptomics. Nat. Protoc. 20, 180\u2013219 (2025).","journal-title":"Nat. Protoc."},{"key":"71121_CR50","doi-asserted-by":"publisher","unstructured":"Ganguly, D. et al. Pleiotrophin drives a prometastatic immune niche in breast cancer. J. Exp. Med. 220. https:\/\/doi.org\/10.1084\/jem.20220610 (2023).","DOI":"10.1084\/jem.20220610"},{"key":"71121_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41419-021-03426-z","volume":"12","author":"L Klemke","year":"2021","unstructured":"Klemke, L. et al. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer. Cell Death Dis. 12, 155 (2021).","journal-title":"Cell Death Dis."},{"key":"71121_CR52","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massagu\u00e9, J. Transforming Growth Factor-\u03b2 Signaling in Immunity and Cancer. Immunity 50, 924\u2013940 (2019).","journal-title":"Immunity"},{"key":"71121_CR53","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/j.1600-6143.2004.00566.x","volume":"4","author":"S Fu","year":"2004","unstructured":"Fu, S. et al. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am. J. Transpl. 4, 1614\u20131627 (2004).","journal-title":"Am. J. Transpl."},{"key":"71121_CR54","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"71121_CR55","doi-asserted-by":"publisher","first-page":"52294","DOI":"10.18632\/oncotarget.10561","volume":"7","author":"F Zhang","year":"2016","unstructured":"Zhang, F. et al. TGF-\u03b2 induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget 7, 52294\u201352306 (2016).","journal-title":"Oncotarget"},{"key":"71121_CR56","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200684RR","volume":"36","author":"N Sethakorn","year":"2022","unstructured":"Sethakorn, N. et al. Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform. Faseb J. 36, e22540 (2022).","journal-title":"Faseb J."},{"key":"71121_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75265-9","volume":"14","author":"E Heninger","year":"2024","unstructured":"Heninger, E. et al. Dynamic reciprocal interactions between activated T cells and tumor associated macrophages drive macrophage reprogramming and proinflammatory T cell migration within prostate tumor models. Sci. Rep. 14, 24230 (2024).","journal-title":"Sci. Rep."},{"key":"71121_CR58","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/pros.70000","volume":"85","author":"MN Sharifi","year":"2025","unstructured":"Sharifi, M. N. et al. Transcriptomic Signatures of Monocyte-Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer. Prostate 85, 1168\u20131180 (2025).","journal-title":"Prostate"},{"key":"71121_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"71121_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"71121_CR61","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl. Acad. Sci. USA 116, 11428\u201311436 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71121_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe2261","volume":"7","author":"SH Park","year":"2021","unstructured":"Park, S. H. et al. Posttranslational regulation of FOXA1 by Polycomb and BUB3\/USP7 deubiquitin complex in prostate cancer. Sci. Adv. 7, eabe2261 (2021).","journal-title":"Sci. Adv."},{"key":"71121_CR63","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1172\/JCI128212","volume":"129","author":"MP Labrecque","year":"2019","unstructured":"Labrecque, M. P. et al. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. J. Clin. Invest 129, 4492\u20134505 (2019).","journal-title":"J. Clin. Invest"},{"key":"71121_CR64","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/00000478-200405000-00014","volume":"28","author":"AV Parwani","year":"2004","unstructured":"Parwani, A. V. et al. Prostate carcinoma with squamous differentiation: an analysis of 33 cases. Am. J. Surg. Pathol. 28, 651\u2013657 (2004).","journal-title":"Am. J. Surg. Pathol."},{"key":"71121_CR65","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","volume":"384","author":"MM Awad","year":"2021","unstructured":"Awad, M. M. et al. Acquired Resistance to KRASG12C Inhibition in Cancer. N. Engl. J. Med. 384, 2382\u20132393 (2021).","journal-title":"N. Engl. J. Med."},{"key":"71121_CR66","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1158\/1078-0432.CCR-19-3563","volume":"26","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. et al. Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer. Clin. Cancer Res. 26, 2654\u20132663 (2020).","journal-title":"Clin. Cancer Res"},{"key":"71121_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s44319-024-00335-y","volume":"26","author":"D De Felice","year":"2025","unstructured":"De Felice, D. et al. Rar\u03b3-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer. EMBO Rep. 26, 443\u2013469 (2025).","journal-title":"EMBO Rep."},{"key":"71121_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34251-3","volume":"13","author":"JI Warrick","year":"2022","unstructured":"Warrick, J. I. et al. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. Nat. Commun. 13, 6575 (2022).","journal-title":"Nat. Commun."},{"key":"71121_CR69","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun, A. et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur. Urol. 77, 420\u2013433 (2020).","journal-title":"Eur. Urol."},{"key":"71121_CR70","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1126\/science.abn0478","volume":"377","author":"JM Chan","year":"2022","unstructured":"Chan, J. M. et al. Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science 377, 1180\u20131191 (2022).","journal-title":"Science"},{"key":"71121_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/science.add5327","volume":"380","author":"C Burdziak","year":"2023","unstructured":"Burdziak, C. et al. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis. Science 380, eadd5327 (2023).","journal-title":"Science"},{"key":"71121_CR72","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197\u2013218 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"71121_CR73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40425-018-0356-4","volume":"6","author":"RB Holmgaard","year":"2018","unstructured":"Holmgaard, R. B. et al. Targeting the TGF\u03b2 pathway with galunisertib, a TGF\u03b2RI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade. J. Immunother. Cancer 6, 47 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"71121_CR74","doi-asserted-by":"publisher","first-page":"e53501","DOI":"10.1371\/journal.pone.0053501","volume":"8","author":"A Birbach","year":"2013","unstructured":"Birbach, A. Use of PB-Cre4 mice for mosaic gene deletion. PLoS One 8, e53501 (2013).","journal-title":"PLoS One"},{"key":"71121_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"71121_CR76","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"71121_CR77","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1093\/bioinformatics\/btaa1011","volume":"36","author":"DG Bunis","year":"2021","unstructured":"Bunis, D. G., Andrews, J., Fragiadakis, G. K., Burt, T. D. & Sirota, M. dittoSeq: universal user-friendly single-cell and bulk RNA sequencing visualization toolkit. Bioinformatics 36, 5535\u20135536 (2021).","journal-title":"Bioinformatics"},{"key":"71121_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"71121_CR79","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"71121_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"71121_CR81","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"71121_CR82","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.21105\/joss.03167","volume":"6","author":"I Patil","year":"2021","unstructured":"Patil, I. Visualizations with statistical details: The \u2018ggstatsplot\u2019 approach. J. Open Source Softw. 6, 3167 (2021).","journal-title":"J. Open Source Softw."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71121-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:02:31Z","timestamp":1779408151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71121-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71121"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71121-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4572"}}